Solara Active Pharma Sciences Limited (SOLARA) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.39x

Solara Active Pharma Sciences Limited (SOLARA) has a Cash Flow Reinvestment Rate of 0.39x as of September 2025, reinvesting Rs286.00 Million (capex Rs286.00 Million ) from operating cash flow of Rs740.70 Million. See SOLARA free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.39x
(Capex + Investments) / Operating CF

Total Reinvested

Rs286.00 Million
Capex + Investments

Operating Cash Flow

Rs740.70 Million
INR

Capital Expenditures

Rs286.00 Million
INR

Solara Active Pharma Sciences Limited Cash Flow Reinvestment Rate (2017–2025)

Historical reinvestment intensity for Solara Active Pharma Sciences Limited across 8 annual periods. For the full cash flow conversion analysis, see SOLARA operating cash flow.

Annual Cash Flow Reinvestment Rate for Solara Active Pharma Sciences Limited (2017–2025)

Year-by-year capital reinvestment analysis for Solara Active Pharma Sciences Limited. See Solara Active Pharma Sciences Limited leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (INR) Operating CF Capex YoY Change
2025 0.36x Rs767.70 Million Rs2.13 Billion Rs399.40 Million ▼ -11.9%
2024 0.41x Rs445.70 Million Rs1.09 Billion Rs410.60 Million ▼ -66.8%
2023 1.23x Rs1.92 Billion Rs1.56 Billion Rs1.11 Billion ▲ +9.7%
2021 1.12x Rs1.75 Billion Rs1.55 Billion Rs1.74 Billion ▲ +2.0%
2020 1.10x Rs2.69 Billion Rs2.44 Billion Rs2.69 Billion ▲ +232.5%
2019 0.33x Rs529.43 Million Rs1.60 Billion Rs525.43 Million ▼ -53.6%
2018 0.71x Rs351.36 Million Rs492.23 Million Rs347.36 Million ▲ +0.0%
2017 0.71x Rs351.36 Million Rs492.23 Million Rs347.36 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow